What we achieved

  • Confidence

    Restored, Trust Rebuilt

  • Quality

    Elevated, Risks Reduced

  • Accelerated

    Delivery

To who

Overview

  • Part 1

    Challenge

    Despite significant investment in Agile transformation, the enterprise struggled to convert process adoption into measurable outcomes. Missed commitments and unmet expectations fueled skepticism, highlighting that true agility demands alignment, accountability, and trust between business and technology.

  • Part 2

    Solution

    To overcome these challenges, the pharma enterprise deployed HCL DevOps Velocity, establishing real-time visibility and a single source of truth for performance. Actionable metrics illuminated bottlenecks and delivery gaps, enabling data-driven planning, better alignment with business priorities, and a culture of transparency and continuous improvement that rebuilt trust across teams and stakeholders.

  • Part 3

    Results

    Early adoption of HCL DevOps Velocity saw faster, more predictable delivery, improved product quality, and restored stakeholder confidence. By increasing testing cycles and accelerating releases, the enterprise strengthened trust between business and technology while driving measurable digital outcomes.

The Challenge

A large multinational enterprise had invested significant time, money, and effort in transforming seven lines of business to adopt “Agile” ways of working. For those who are unfamiliar, Agile is a structured learning process offering practices to improve project efficiency, adaptability, and collaboration, moving beyond software development to business operations. Many of this company’s teams had undergone Agile training and adopted standard practices, such as planning in program increments and sprints, and documenting work through epics, features, and user stories.

However, despite these efforts, they struggled to translate process adoption into tangible business outcomes. Teams were still failing to meet commitments to their business partners and users, creating a perception that Agile was more about following rituals than driving results.

Frustration mounted among stakeholders as expectations went unmet. What was intended to build greater agility and trust instead fueled skepticism, with many business leaders viewing the initiative as an overhyped trend. The growing disconnect led to declining confidence between business and technology, with trust at its lowest point.

 

The Solution

To address these challenges, the pharma enterprise implemented HCL DevOps Velocity as Value Stream Management solution to establish real-time visibility and measurement across the organization’s teams and as a whole. HCL DevOps Velocity proved to be a single source of truth for performance, enabling leaders to move beyond subjective perceptions and adopt data-driven decision-making.

HCL DevOps Velocity provided actionable metrics that highlighted bottlenecks, capacity constraints, and delivery gaps, breaking the recurring cycle of over-commitment and under-delivery. By tracking progress against realistic benchmarks, teams were able to plan more effectively and align delivery with business priorities.

Also, HCL DevOps Velocity fostered a culture of continuous improvement and transparency. The platform’s metrics were easily shared with all stakeholders, reinforcing accountability while rebuilding trust.

The Results

The lines of business that adopted HCL DevOps Velocity earliest experienced measurable improvements in delivery performance. Teams achieved significantly higher levels of on-time and on-scope commitments, which in turn restored confidence among stakeholders. The renewed ability to deliver reliably strengthened the partnership between business and technology, rebuilding trust across the enterprise.

By leveraging Velocity’s pipeline GRC-enabled CI/CD capabilities, the enterprise was able to increase the number of testing cycles within each iteration consistently and objectively. This led to more frequent production releases, faster code turnaround, and earlier defect discovery. As a result, defect escape rates decreased, improving overall product quality while reducing risks associated with late-stage defects.

Together, these improvements enabled the enterprise to accelerate delivery, as well as achieve higher predictability, quality, and trust in its digital initiatives.

About the company

The company is a leading global provider committed to advancing the treatment of diseases across diverse medical fields. With a strong focus on innovation, it develops solutions and technologies that address some of the most critical challenges in healthcare. By combining scientific expertise with cutting-edge research, the company is dedicated to improving patient outcomes and enhancing the quality of care worldwide.

Related Capabilities

Hi, I am HCLSoftware Virtual Assistant.